Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ·Healthcare·Biotechnology
$8.40
+0.30%
Mkt Cap $677.14M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (19 analysts)
$22.00
Range $18.00 – $28.00
Implied Upside
+162.1%
Consensus $22.00 vs current $8.40
NASDAQ·Healthcare·Biotechnology
$8.40
+0.30%
Mkt Cap $677.14M
Buy
6
Hold
0
Sell
0
Price Target (19 analysts)
$22.00
Range $18.00 – $28.00
+162.1%
Consensus $22.00 vs current $8.40